Noah-David Hirsch

ORCID: 0000-0003-4511-862X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Research and Treatments
  • Escherichia coli research studies
  • Virus-based gene therapy research
  • Digestive system and related health
  • CRISPR and Genetic Engineering

Klinikum rechts der Isar
2022

Technical University of Munich
2022

Abstract The B subunit of bacterial Shiga toxin (STxB) is nontoxic and has low immunogenicity. Its receptor, the glycosphingolipid Gb3/CD77, overexpressed on cell surface human colorectal cancer. We tested whether genetic porcine models, closely resembling anatomy pathophysiology, can be used to exploit tumor-targeting potential STxB. In accordance with findings cancer, pig model APC1311 bound STxB in tumors, but not normal colon or jejunum, except for putative enteroendocrine cells. primary...

10.1158/1535-7163.mct-21-0445 article EN Molecular Cancer Therapeutics 2022-01-27

<div>Abstract<p>The B subunit of bacterial Shiga toxin (STxB) is nontoxic and has low immunogenicity. Its receptor, the glycosphingolipid Gb<sub>3</sub>/CD77, overexpressed on cell surface human colorectal cancer. We tested whether genetic porcine models, closely resembling anatomy pathophysiology, can be used to exploit tumor-targeting potential STxB. In accordance with findings cancer, pig model <i>APC<sup>1311</sup></i> bound STxB in tumors,...

10.1158/1535-7163.c.6543525.v1 preprint EN 2023-04-03

<div>Abstract<p>The B subunit of bacterial Shiga toxin (STxB) is nontoxic and has low immunogenicity. Its receptor, the glycosphingolipid Gb<sub>3</sub>/CD77, overexpressed on cell surface human colorectal cancer. We tested whether genetic porcine models, closely resembling anatomy pathophysiology, can be used to exploit tumor-targeting potential STxB. In accordance with findings cancer, pig model <i>APC<sup>1311</sup></i> bound STxB in tumors,...

10.1158/1535-7163.c.6543525 preprint EN 2023-04-03
Coming Soon ...